Last ween brought a wave of insider activity across the insurance and reinsurance sector, with compensation vesting , executive departures, and at least one notable open-market sale.
The headline transaction belongs to Allstate's Thomas Wilson, who sold $3.5 million in company stock. Elsewhere, compensation-related activity dominated the week as annual equity grant cycles triggered simultaneous vesting events at RGA, Arthur J. Gallagher, Aon, Marsh & McLennan, Everest Group, and Erie Indemnity, with executives across the sector converting 2023 performance grants to stock despite current year stock performance challenges.
This week's filings offer a snapshot of how US insurance executives are positioned heading into Q2, and where, quietly, some are beginning to take chips off the table.
